免费日韩片_欧美成人精品一区二区男人小说_国产乱码一区二区三区四区_国产精品国产三级国产aⅴ入口_成人看的污污超级黄网站免费_欧美一级在线免费观看_成人午夜免费无码福利片_国产乱人伦偷精品视频色欲_aaa少妇高潮大片免费看_国产精品1234_亚洲精品国产suv一区88_中文字字幕在线中文无码_精品亚洲区_午夜九九九_国产av国片精品jk制服丝袜_色综合亚洲_亚洲成av人片无码bt种子下载_欧美色就色_精品少妇的一区二区三区四区_男人用嘴添女人下身免费视频

Chief executives of Generon Corp, at E-town, Beijing, on Nov 21. [Photo/E-Times]

The Generon Corp, a rising star in the bio-medicine industry, has come up with an innovative path to push clinical tests of its pharmaceuticals to overseas market, E-Times, the Beijing Economic Technological Development Area (E-town) weekly, reported Nov 21.

Many of its products tested in western countries meet European Medicines Agency and the US’s Food and Drug Administration standards and break the western dominance in their field, with acknowledged patents. The company understands international research and development and says it wants to help its Chinese counterparts by sharing its experience.

The company was started in 2004 by three Chinese who got their PhD degrees in the US and who wanted to expand their business so they established a production center in E-town, after doing survey of China's science and technology parks, because of its preferential policies. Generon has grown fast and has been good at commercializing its findings.

The three founders have many years of clinical trial experience and international research. Huang Yuliang, the CEO, has 20 years of experience in bio-medical production management and plant construction and operations, while Yan Xiaoqiang, the chief science executive, has years of work in molecular research related to human diseases, and Tang Kaiyang, chief medical executive, specializes in international drug policies and laws, and clinical medicine licensing.

Edited by Fang Sha and Roger Bradshaw